Abstract
Peripheral vascular disease can compromise the blood supply to the lower limb with amputation being necessary in severe cases. Reduced blood flow may be due to arterial occlusive disease or constriction of skeletal microvessels with the resultant ischaemia causing pain, tissue damage, ulceration and gangrene. These events are associated with endothelial damage or dysfunction: endothelin-1 is implicated as a mediator via its constrictor, proinflammatory and proliferative actions. Raised plasma and tissue levels of this peptide have been described in various ischaemic conditions, including peripheral vascular disease. Here, the possible role of endothelin-1 in peripheral vascular disease is discussed and potential therapeutic tools are considered.
Keywords: endothelin, receptors, ischaemia, reperfusion, vascular disease, pathology
Current Vascular Pharmacology
Title: A Role for Endothelin-1 in Peripheral Vascular Disease
Volume: 3 Issue: 4
Author(s): Janice C.S. Tsui and Michael R. Dashwood
Affiliation:
Keywords: endothelin, receptors, ischaemia, reperfusion, vascular disease, pathology
Abstract: Peripheral vascular disease can compromise the blood supply to the lower limb with amputation being necessary in severe cases. Reduced blood flow may be due to arterial occlusive disease or constriction of skeletal microvessels with the resultant ischaemia causing pain, tissue damage, ulceration and gangrene. These events are associated with endothelial damage or dysfunction: endothelin-1 is implicated as a mediator via its constrictor, proinflammatory and proliferative actions. Raised plasma and tissue levels of this peptide have been described in various ischaemic conditions, including peripheral vascular disease. Here, the possible role of endothelin-1 in peripheral vascular disease is discussed and potential therapeutic tools are considered.
Export Options
About this article
Cite this article as:
Tsui C.S. Janice and Dashwood R. Michael, A Role for Endothelin-1 in Peripheral Vascular Disease, Current Vascular Pharmacology 2005; 3 (4) . https://dx.doi.org/10.2174/157016105774329444
| DOI https://dx.doi.org/10.2174/157016105774329444 |
Print ISSN 1570-1611 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Anticoagulation Therapy in Special Populations with Atrial Fibrillation: Challenges and Advances
Atrial fibrillation (AF) remains the most common sustained cardiac arrhythmia worldwide, and anticoagulation therapy is central to preventing AF-related thromboembolic complications. However, clinical management becomes increasingly complex in special populations characterized by comorbidities, frailty, or altered pharmacokinetics, such as the elderly, patients with renal or hepatic impairment, those with prior ...read more
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
P2X7 Receptors: Channels, Pores and More
CNS & Neurological Disorders - Drug Targets Therapeutic Potential of Targeting Protease Activated Receptors in Cardiovascular Diseases
Current Pharmaceutical Design Cell and Gene Therapies for Refractory Epilepsy
Current Neuropharmacology Exploring the Promising Role of Guggulipid in Rheumatoid Arthritis Management: An In-depth Analysis
Current Rheumatology Reviews Role of Advanced Glycation End Products in Diabetic Neuropathy
Current Pharmaceutical Design LncRNA as a Therapeutic Target for Angiogenesis
Current Topics in Medicinal Chemistry The Resurgence of Aldosterone in Hypertension and Cardiovascular Disease
Current Hypertension Reviews Iptakalim Hydrochloride and Neuronal Protection
Current Neuropharmacology ErbB Targeted Drugs and Angiogenesis
Current Vascular Pharmacology IgG4 Related Syndrome: Another Multiorgan Disease in the Interest Field of Internal Medicine
Current Pharmaceutical Design Using Microgravity for Defining Novel Anti-Atherosclerotic Therapy
Current Genomics Artery of Percheron Infarction: A Characteristic Pattern of Ischemia and Variable Clinical Presentation: A Literature Review
Current Medical Imaging Current Antioxidant Molecular Therapies for Oxidative Stress-Related Ailments
Current Gene Therapy Anti-inflammatory Natural Prenylated Phenolic Compounds - Potential Lead Substances
Current Medicinal Chemistry Cellular and Molecular Effects of Macrolides on Leukocyte Function
Current Pharmaceutical Design Early Cerebral Infarction Following Aneurysmal Subarachnoid Hemorrhage: Frequency, Risk Factors, Patterns, and Prognosis
Current Neurovascular Research Therapeutic Modulation of Lipoprotein-associated Phospholipase A2 (Lp-PLA2)
Current Pharmaceutical Design The Secretin/Pituitary Adenylate Cyclase-Activating Polypeptide/ Vasoactive Intestinal Polypeptide Superfamily in the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Inflammatory Mechanisms and Redox Status in Periodontal and Cardiometabolic Diseases: Effects of Adjunctive Nutritional Antioxidants and Statins
Infectious Disorders - Drug Targets The Role of Coagulation and Fibrinolysis in the Pathogenesis of Acute Lung Injury
Current Respiratory Medicine Reviews





